171 related articles for article (PubMed ID: 24260260)
1. Identification of highly methylated genes across various types of B-cell non-hodgkin lymphoma.
Bethge N; Honne H; Hilden V; Trøen G; Eknæs M; Liestøl K; Holte H; Delabie J; Smeland EB; Lind GE
PLoS One; 2013; 8(11):e79602. PubMed ID: 24260260
[TBL] [Abstract][Full Text] [Related]
2. A gene panel, including LRP12, is frequently hypermethylated in major types of B-cell lymphoma.
Bethge N; Honne H; Andresen K; Hilden V; Trøen G; Liestøl K; Holte H; Delabie J; Lind GE; Smeland EB
PLoS One; 2014; 9(9):e104249. PubMed ID: 25226156
[TBL] [Abstract][Full Text] [Related]
3. Epigenetic regulation of CD44 in Hodgkin and non-Hodgkin lymphoma.
Eberth S; Schneider B; Rosenwald A; Hartmann EM; Romani J; Zaborski M; Siebert R; Drexler HG; Quentmeier H
BMC Cancer; 2010 Sep; 10():517. PubMed ID: 20920234
[TBL] [Abstract][Full Text] [Related]
4. Discovery of novel epigenetic markers in non-Hodgkin's lymphoma.
Shi H; Guo J; Duff DJ; Rahmatpanah F; Chitima-Matsiga R; Al-Kuhlani M; Taylor KH; Sjahputera O; Andreski M; Wooldridge JE; Caldwell CW
Carcinogenesis; 2007 Jan; 28(1):60-70. PubMed ID: 16774933
[TBL] [Abstract][Full Text] [Related]
5. Colorectal cancer DNA methylation marker panel validated with high performance in Non-Hodgkin lymphoma.
Bethge N; Lothe RA; Honne H; Andresen K; Trøen G; Eknæs M; Liestøl K; Holte H; Delabie J; Smeland EB; Lind GE
Epigenetics; 2014 Mar; 9(3):428-36. PubMed ID: 24362313
[TBL] [Abstract][Full Text] [Related]
6. Epigenetic silencing of miR-342-3p in B cell lymphoma and its impact on autophagy.
Zhang MY; Calin GA; Yuen KS; Jin DY; Chim CS
Clin Epigenetics; 2020 Oct; 12(1):150. PubMed ID: 33076962
[TBL] [Abstract][Full Text] [Related]
7. Epigenetic silencing of the 3p22 tumor suppressor DLEC1 by promoter CpG methylation in non-Hodgkin and Hodgkin lymphomas.
Wang Z; Li L; Su X; Gao Z; Srivastava G; Murray PG; Ambinder R; Tao Q
J Transl Med; 2012 Oct; 10():209. PubMed ID: 23050586
[TBL] [Abstract][Full Text] [Related]
8. Gene expression analysis provides a potential rationale for revising the histological grading of follicular lymphomas.
Piccaluga PP; Califano A; Klein U; Agostinelli C; Bellosillo B; Gimeno E; Serrano S; Solè F; Zang Y; Falini B; Zinzani PL; Pileri SA
Haematologica; 2008 Jul; 93(7):1033-8. PubMed ID: 18492688
[TBL] [Abstract][Full Text] [Related]
9. State of the Art and Future Needs in Cytogenetic/Molecular Genetics/Arrays in childhood lymphoma: summary report of workshop at the First International Symposium on childhood and adolescent non-Hodgkin lymphoma, April 9, 2003, New York City, NY.
Heerema NA; Bernheim A; Lim MS; Look AT; Pasqualucci L; Raetz E; Sanger WG; Cairo MS
Pediatr Blood Cancer; 2005 Oct; 45(5):616-22. PubMed ID: 16127683
[TBL] [Abstract][Full Text] [Related]
10. Differential DNA methylation of gene promoters in small B-cell lymphomas.
Guo J; Burger M; Nimmrich I; Maier S; Becker E; Genc B; Duff D; Rahmatpanah F; Chitma-Matsiga R; Shi H; Berlin K; Huang TH; Caldwell CW
Am J Clin Pathol; 2005 Sep; 124(3):430-9. PubMed ID: 16191512
[TBL] [Abstract][Full Text] [Related]
11. Tumor-specific methylation of the 8p22 tumor suppressor gene DLC1 is an epigenetic biomarker for Hodgkin, nasal NK/T-cell and other types of lymphomas.
Ying J; Li H; Murray P; Gao Z; Chen YW; Wang Y; Lee KY; Chan AT; Ambinder RF; Srivastava G; Tao Q
Epigenetics; 2007; 2(1):15-21. PubMed ID: 17965626
[TBL] [Abstract][Full Text] [Related]
12. Identification of two unannotated miRNAs in classic Hodgkin lymphoma cell lines.
Ustaszewski A; Paczkowska J; Janiszewska J; Bernhart SH; Bein J; Russiñol N; Hansmann ML; Chapaprieta V; Martín-Subero JI; Siebert R; Hartmann S; Giefing M
PLoS One; 2023; 18(3):e0283186. PubMed ID: 36961799
[TBL] [Abstract][Full Text] [Related]
13. CD10 and BCL-6 expression in paraffin sections of normal lymphoid tissue and B-cell lymphomas.
Dogan A; Bagdi E; Munson P; Isaacson PG
Am J Surg Pathol; 2000 Jun; 24(6):846-52. PubMed ID: 10843287
[TBL] [Abstract][Full Text] [Related]
14. DNA methylation profiling of transcription factor genes in normal lymphocyte development and lymphomas.
Ivascu C; Wasserkort R; Lesche R; Dong J; Stein H; Thiel A; Eckhardt F
Int J Biochem Cell Biol; 2007; 39(7-8):1523-38. PubMed ID: 17433759
[TBL] [Abstract][Full Text] [Related]
15. Association between lymphoma prognosis and aberrant methylation of ID4 and ZO-1 in bone marrow and paraffin-embedded lymphoma tissues of treatment-naive patients.
Cen J; Shen J; Wang X; Kang H; Wang L; Sun L; Li Y; Yu L
Oncol Rep; 2013 Jul; 30(1):455-61. PubMed ID: 23670122
[TBL] [Abstract][Full Text] [Related]
16. New insights into the biology and origin of mature aggressive B-cell lymphomas by combined epigenomic, genomic, and transcriptional profiling.
Martín-Subero JI; Kreuz M; Bibikova M; Bentink S; Ammerpohl O; Wickham-Garcia E; Rosolowski M; Richter J; Lopez-Serra L; Ballestar E; Berger H; Agirre X; Bernd HW; Calvanese V; Cogliatti SB; Drexler HG; Fan JB; Fraga MF; Hansmann ML; Hummel M; Klapper W; Korn B; Küppers R; Macleod RA; Möller P; Ott G; Pott C; Prosper F; Rosenwald A; Schwaenen C; Schübeler D; Seifert M; Stürzenhofecker B; Weber M; Wessendorf S; Loeffler M; Trümper L; Stein H; Spang R; Esteller M; Barker D; Hasenclever D; Siebert R;
Blood; 2009 Mar; 113(11):2488-97. PubMed ID: 19075189
[TBL] [Abstract][Full Text] [Related]
17. Epigenome-wide ovarian cancer analysis identifies a methylation profile differentiating clear-cell histology with epigenetic silencing of the HERG K+ channel.
Cicek MS; Koestler DC; Fridley BL; Kalli KR; Armasu SM; Larson MC; Wang C; Winham SJ; Vierkant RA; Rider DN; Block MS; Klotzle B; Konecny G; Winterhoff BJ; Hamidi H; Shridhar V; Fan JB; Visscher DW; Olson JE; Hartmann LC; Bibikova M; Chien J; Cunningham JM; Goode EL
Hum Mol Genet; 2013 Aug; 22(15):3038-47. PubMed ID: 23571109
[TBL] [Abstract][Full Text] [Related]
18. Expression of the NF-kappaB targets BCL2 and BIRC5/Survivin characterizes small B-cell and aggressive B-cell lymphomas, respectively.
Tracey L; Pérez-Rosado A; Artiga MJ; Camacho FI; Rodríguez A; Martínez N; Ruiz-Ballesteros E; Mollejo M; Martinez B; Cuadros M; Garcia JF; Lawler M; Piris MA
J Pathol; 2005 Jun; 206(2):123-34. PubMed ID: 15880597
[TBL] [Abstract][Full Text] [Related]
19. Constitutively overexpressed 21 kDa protein in Hodgkin lymphoma and aggressive non-Hodgkin lymphomas identified as cytochrome B5b (CYB5B).
Murphy D; Parker J; Zhou M; Fadlelmola FM; Steidl C; Karsan A; Gascoyne RD; Chen H; Banerjee D
Mol Cancer; 2010 Jan; 9():14. PubMed ID: 20100355
[TBL] [Abstract][Full Text] [Related]
20. Aberrant promoter methylation of multiple genes throughout the clinico-pathologic spectrum of B-cell neoplasia.
Rossi D; Capello D; Gloghini A; Franceschetti S; Paulli M; Bhatia K; Saglio G; Vitolo U; Pileri SA; Esteller M; Carbone A; Gaidano G
Haematologica; 2004 Feb; 89(2):154-64. PubMed ID: 15003890
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
